Literature DB >> 23371307

Potential role of naturally derived polyphenols and their nanotechnology delivery in cancer.

Tasnima Khushnud1, Shaker A Mousa.   

Abstract

Polyphenols are natural compounds found in plants, fruits, chocolate, and beverages such as tea and wine. To date, the majority of polyphenol research shows them to have anticancer activity in cell lines and animal models. Some human clinical trials also indicate possible anticancer benefits are associated with polyphenols. A problem with polyphenols is their short half-life and low bioavailability; thus the use of nanoparticles to enhance their delivery is a new research field. A Pubmed search was conducted to find in vitro, in vivo, and human clinical trials done within the past 10 years involving the use of polyphenols against different cancer types, and for studies done within the past 5 years on the use of nanoparticles to enhance polyphenol delivery. Based on the studies found, it is observed that polyphenols may be a potential alternative or additive therapy against cancer, and the use of nanoparticles to enhance their delivery to tumors is a promising approach. However, further human clinical trials are necessary to better understand the use of polyphenols as well as their nanoparticle-mediated delivery.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23371307     DOI: 10.1007/s12033-012-9623-7

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  61 in total

1.  Quantitative analysis of albumin uptake and transport in the rat microvessel endothelial monolayer.

Authors:  Theresa A John; Stephen M Vogel; Chinnaswamy Tiruppathi; Asrar B Malik; Richard D Minshall
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2003-01       Impact factor: 5.464

2.  Epigallocatechin gallate-loaded polysaccharide nanoparticles for prostate cancer chemoprevention.

Authors:  Sandra Rocha; Roman Generalov; Maria do Carmo Pereira; Ivone Peres; Petras Juzenas; Manuel A N Coelho
Journal:  Nanomedicine (Lond)       Date:  2011-01       Impact factor: 5.307

Review 3.  Pharmacytes: an ideal vehicle for targeted drug delivery.

Authors:  Robert A Freitas
Journal:  J Nanosci Nanotechnol       Date:  2006 Sep-Oct

4.  Enhancement of cancer chemosensitization potential of cisplatin by tea polyphenols poly(lactide-co-glycolide) nanoparticles.

Authors:  Madhulika Singh; Priyanka Bhatnagar; Amit K Srivastava; Pradeep Kumar; Yogeshwer Shukla; Kailash C Gupta
Journal:  J Biomed Nanotechnol       Date:  2011-02       Impact factor: 4.099

5.  Antiproliferative effect of quercetin in the human U138MG glioma cell line.

Authors:  Elizandra Braganhol; Lauren L Zamin; Andrés Delgado Canedo; Fabiana Horn; Alessandra S K Tamajusuku; Márcia R Wink; Christianne Salbego; Ana M O Battastini
Journal:  Anticancer Drugs       Date:  2006-07       Impact factor: 2.248

6.  Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis.

Authors:  Victoria A Brown; Ketan R Patel; Maria Viskaduraki; James A Crowell; Marjorie Perloff; Tristan D Booth; Grygoriy Vasilinin; Ananda Sen; Anna Maria Schinas; Gianfranca Piccirilli; Karen Brown; William P Steward; Andreas J Gescher; Dean E Brenner
Journal:  Cancer Res       Date:  2010-10-08       Impact factor: 12.701

7.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

Authors:  Eugenia E Calle; Carmen Rodriguez; Kimberly Walker-Thurmond; Michael J Thun
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

8.  Introducing nanochemoprevention as a novel approach for cancer control: proof of principle with green tea polyphenol epigallocatechin-3-gallate.

Authors:  Imtiaz A Siddiqui; Vaqar M Adhami; Dhruba J Bharali; Bilal B Hafeez; Mohammad Asim; Sabih I Khwaja; Nihal Ahmad; Huadong Cui; Shaker A Mousa; Hasan Mukhtar
Journal:  Cancer Res       Date:  2009-02-17       Impact factor: 12.701

Review 9.  Nanocarriers as an emerging platform for cancer therapy.

Authors:  Dan Peer; Jeffrey M Karp; Seungpyo Hong; Omid C Farokhzad; Rimona Margalit; Robert Langer
Journal:  Nat Nanotechnol       Date:  2007-12       Impact factor: 39.213

10.  (-)-Epigallocatechin gallate sensitizes breast cancer cells to paclitaxel in a murine model of breast carcinoma.

Authors:  Ting Luo; Jiao Wang; Yancun Yin; Hui Hua; Jing Jing; Xiangming Sun; Minjing Li; You Zhang; Yangfu Jiang
Journal:  Breast Cancer Res       Date:  2010-01-15       Impact factor: 6.466

View more
  9 in total

1.  Resveratrol-loaded nanoparticles based on poly(epsilon-caprolactone) and poly(D,L-lactic-co-glycolic acid)-poly(ethylene glycol) blend for prostate cancer treatment.

Authors:  Vanna Sanna; Imtiaz Ahmad Siddiqui; Mario Sechi; Hasan Mukhtar
Journal:  Mol Pharm       Date:  2013-09-04       Impact factor: 4.939

Review 2.  Biocompatible and biodegradable nanoparticles for enhancement of anti-cancer activities of phytochemicals.

Authors:  Chuan Li; Jia Zhang; Yu-Jiao Zu; Shu-Fang Nie; Jun Cao; Qian Wang; Shao-Ping Nie; Ze-Yuan Deng; Ming-Yong Xie; Shu Wang
Journal:  Chin J Nat Med       Date:  2015-09

Review 3.  Molecular signaling mechanisms behind polyphenol-induced bone anabolism.

Authors:  Elisa Torre
Journal:  Phytochem Rev       Date:  2017-08-31       Impact factor: 5.374

4.  Dark Chocolate: Opportunity for an Alliance between Medical Science and the Food Industry?

Authors:  Ivan M Petyaev; Yuriy K Bashmakov
Journal:  Front Nutr       Date:  2017-09-26

5.  Nanoparticulated Honokiol Mitigates Cisplatin-Induced Chronic Kidney Injury by Maintaining Mitochondria Antioxidant Capacity and Reducing Caspase 3-Associated Cellular Apoptosis.

Authors:  Hung-Ting Liu; Tse-En Wang; Yu-Ting Hsu; Chi-Chung Chou; Kai-Hung Huang; Cheng-Chih Hsu; Hong-Jen Liang; Hui-Wen Chang; Tzong-Huei Lee; Pei-Shiue Tsai
Journal:  Antioxidants (Basel)       Date:  2019-10-09

Review 6.  Natural product-based nanomedicine: recent advances and issues.

Authors:  Rebekah Watkins; Ling Wu; Chenming Zhang; Richey M Davis; Bin Xu
Journal:  Int J Nanomedicine       Date:  2015-09-28

7.  Bioavailability of polyphenol liposomes: a challenge ahead.

Authors:  Nathalie Mignet; Johanne Seguin; Guy G Chabot
Journal:  Pharmaceutics       Date:  2013-09-17       Impact factor: 6.321

Review 8.  Targeting Nitric Oxide with Natural Derived Compounds as a Therapeutic Strategy in Vascular Diseases.

Authors:  Maurizio Forte; Valeria Conti; Antonio Damato; Mariateresa Ambrosio; Annibale A Puca; Sebastiano Sciarretta; Giacomo Frati; Carmine Vecchione; Albino Carrizzo
Journal:  Oxid Med Cell Longev       Date:  2016-08-29       Impact factor: 6.543

9.  Pterostilbene Decreases the Antioxidant Defenses of Aggressive Cancer Cells In Vivo: A Physiological Glucocorticoids- and Nrf2-Dependent Mechanism.

Authors:  María Benlloch; Elena Obrador; Soraya L Valles; María L Rodriguez; J Antoni Sirerol; Javier Alcácer; José A Pellicer; Rosario Salvador; Concha Cerdá; Guillermo T Sáez; José M Estrela
Journal:  Antioxid Redox Signal       Date:  2016-03-15       Impact factor: 8.401

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.